ITTO20040752A1 - TEST PROCEDURE FOR IDENTIFYING INHIBITORS OF EXPRESSION OF E6 AND E7 ONCOPROTEINS OF PAPILLOMA HUMAN VIRUS (HPV) RECOMBINING GUEST CELL AND KIT FOR USING THE ABOVE PROCEDURE - Google Patents

TEST PROCEDURE FOR IDENTIFYING INHIBITORS OF EXPRESSION OF E6 AND E7 ONCOPROTEINS OF PAPILLOMA HUMAN VIRUS (HPV) RECOMBINING GUEST CELL AND KIT FOR USING THE ABOVE PROCEDURE

Info

Publication number
ITTO20040752A1
ITTO20040752A1 ITTO20040752A ITTO20040752A1 IT TO20040752 A1 ITTO20040752 A1 IT TO20040752A1 IT TO20040752 A ITTO20040752 A IT TO20040752A IT TO20040752 A1 ITTO20040752 A1 IT TO20040752A1
Authority
IT
Italy
Prior art keywords
oncoproteins
recombining
hpv
papilloma
kit
Prior art date
Application number
Other languages
Italian (it)
Inventor
Santo Landolfo
David Lembo
Original Assignee
Univ Degli Studi Torino
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Degli Studi Torino filed Critical Univ Degli Studi Torino
Priority to ITTO20040752 priority Critical patent/ITTO20040752A1/en
Publication of ITTO20040752A1 publication Critical patent/ITTO20040752A1/en
Priority to PCT/EP2005/055598 priority patent/WO2006045833A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ITTO20040752 2004-10-29 2004-10-29 TEST PROCEDURE FOR IDENTIFYING INHIBITORS OF EXPRESSION OF E6 AND E7 ONCOPROTEINS OF PAPILLOMA HUMAN VIRUS (HPV) RECOMBINING GUEST CELL AND KIT FOR USING THE ABOVE PROCEDURE ITTO20040752A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ITTO20040752 ITTO20040752A1 (en) 2004-10-29 2004-10-29 TEST PROCEDURE FOR IDENTIFYING INHIBITORS OF EXPRESSION OF E6 AND E7 ONCOPROTEINS OF PAPILLOMA HUMAN VIRUS (HPV) RECOMBINING GUEST CELL AND KIT FOR USING THE ABOVE PROCEDURE
PCT/EP2005/055598 WO2006045833A1 (en) 2004-10-29 2005-10-27 Assay method for identifying inhibitors of the expression of the oncoproteins e6 and e7 of the human papilloma virus (hpv), recombinant host cell and kit for use in the aforesaid method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITTO20040752 ITTO20040752A1 (en) 2004-10-29 2004-10-29 TEST PROCEDURE FOR IDENTIFYING INHIBITORS OF EXPRESSION OF E6 AND E7 ONCOPROTEINS OF PAPILLOMA HUMAN VIRUS (HPV) RECOMBINING GUEST CELL AND KIT FOR USING THE ABOVE PROCEDURE

Publications (1)

Publication Number Publication Date
ITTO20040752A1 true ITTO20040752A1 (en) 2005-01-29

Family

ID=35589609

Family Applications (1)

Application Number Title Priority Date Filing Date
ITTO20040752 ITTO20040752A1 (en) 2004-10-29 2004-10-29 TEST PROCEDURE FOR IDENTIFYING INHIBITORS OF EXPRESSION OF E6 AND E7 ONCOPROTEINS OF PAPILLOMA HUMAN VIRUS (HPV) RECOMBINING GUEST CELL AND KIT FOR USING THE ABOVE PROCEDURE

Country Status (2)

Country Link
IT (1) ITTO20040752A1 (en)
WO (1) WO2006045833A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484732A (en) * 1993-03-22 1996-01-16 The Regents Of The University Of California Transcription factor for regulation of the development of skin and hair
WO1999021979A1 (en) * 1997-10-28 1999-05-06 Maxygen, Inc. Human papillomavirus vectors
WO2003000279A1 (en) * 2001-06-21 2003-01-03 The Brigham And Women's Hospital, Inc. GEMININ AND orc3N INHIBIT REPLICATION OF HERPESVIRUSES, PAPILLOMAVIRUSES, AND POLYOMAVIRUSES
US20060063727A1 (en) * 2002-05-17 2006-03-23 Chawnshang Chang Tr4/tr2 response elements

Also Published As

Publication number Publication date
WO2006045833A1 (en) 2006-05-04

Similar Documents

Publication Publication Date Title
EA200400919A1 (en) METHOD FOR DETECTING THE HUMAN PAPILLOMA VIRUS mRNA
SMT201600278B (en) BENZOSSAZOL CHINASE INHIBITORS AND METHODS OF USE
ITCO20050028A1 (en) COMPLEX OF ACCELERATORS OF PROTON TILES IN PARTICULAR FOR MEDICAL USE
FR16C1012I2 (en) THERAPEUTIC USE OF ANTI-CS1 ANTIBODIES
CY2015050I2 (en) OPTIMIZED EXPRESSION OF HPV 45 L1 IN Yeast
WO2005104755A3 (en) Artificial immune system: methods for making and use
DE602005016800D1 (en) HIF-prolyl hydroxylase ACTIVITY TEST
CY2015052I1 (en) OPTIMIZED EXPRESSION OF HPV 52 L1 IN DOUGH
IL172986A0 (en) Hairpin -labeled probes and methods of use
DE60212044D1 (en) Test of buccal dissolution of pharmaceutically active substances
EP1812012A4 (en) Protein tyrosine phosphatase inhibitors and methods of use thereof
EP1827391A4 (en) Dosage forms and methods of use thereof
EP1660678A4 (en) Mutant adeno-associated virus virions and methods of use thereof
DE602005008419D1 (en) USE OF MELOXICAMIC FORMULATIONS IN VETERINARY MEDICINE
DK1755743T3 (en) Beta-hydroxybutyrate and derivatives for the treatment of depression and anxiety
NO20042710L (en) Disposable dosimeter patch for use in radiation therapy
DK1368060T3 (en) HMGB1 protein inhibitors and / or antagonists for the treatment of vascular disease
WO2010065907A3 (en) Use of a rock inhibitor to sustain primary human keratinocytes in a proliferative state
HK1085378A1 (en) Use of hpv16 and hpv18 as vaccine against one or more of oncogenic hpv type 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68
IL189281A0 (en) In vitro diagnostic method and kit for identification of human papillomavirus in clinical samples
DE10192291D2 (en) Positioning aid for tomographic functional examination of the cervical spine
HRP20090513T1 (en) S-mirtazapine for the treatment of hot flush
DE602004032465D1 (en) REFERENCE STANDARD FOR THE CHARACTERIZATION OF ROSUVASTATIN
ITTO20040752A1 (en) TEST PROCEDURE FOR IDENTIFYING INHIBITORS OF EXPRESSION OF E6 AND E7 ONCOPROTEINS OF PAPILLOMA HUMAN VIRUS (HPV) RECOMBINING GUEST CELL AND KIT FOR USING THE ABOVE PROCEDURE
EP1739419A4 (en) Method of measuring substance by mass spectrometry and kit therefor